Hydroxychloroquine Dosing Guidelines

Standard Dosing for Rheumatic Diseases

The American College of Rheumatology recommends hydroxychloroquine dosing at ≤5 mg/kg actual body weight per day to minimize retinal toxicity risk, with dose reduction of 25% required when eGFR <30 ml/min per 1.73 m² 1, 2, 3
For patients with systemic lupus erythematosus (SLE), the starting dose is 200 mg once daily or 400 mg once daily, and the maximum safe dose is ≤5 mg/kg actual body weight per day to keep retinopathy risk below 2% over 10 years 1, 4, 5
Hydroxychloroquine is recommended for all patients with SLE due to multiple beneficial effects, including reduced flares, organ damage prevention, and improved survival 2, 3, 4

The National Kidney Foundation recommends reducing the hydroxychloroquine dose by 25% when eGFR <30 ml/min per 1.73 m² 2, 3
Reduced renal function is the greatest additional risk factor for retinopathy, and patients with renal insufficiency need lower doses and closer monitoring 1, 2, 3
eGFR <60 ml/min per 1.73 m² is a risk factor requiring earlier ophthalmologic screening (after 1 year instead of 5 years) 2, 3

The primary risk factors for retinopathy are daily dose >5 mg/kg actual body weight, duration of treatment, chronic kidney disease, concomitant tamoxifen use, and pre-existing retinal or macular disease 1, 2, 3, 5
The American Academy of Ophthalmology recommends baseline examination within the first few months of therapy, annual screening beginning after 5 years for low-risk patients, and annual screening beginning after 1 year for high-risk patients 1, 2, 3, 5
East Asian patients require screening beyond central macula due to different retinopathy phenotype (pericentral vascular arcade involvement) 1
The American College of Medical Genetics recommends G6PD testing preferred in men of African, Asian, or Middle Eastern origin before starting therapy due to hemolysis risk 2, 3
The American Heart Association recommends baseline ECG due to QT prolongation risk 6

The evidence clearly demonstrates that actual body weight should be used for dose calculation, as retinopathy risks were statistically similar across BMI groups (15-35 kg/m²) when actual body weight was used 1, 5
Lower doses (2-3 mg/kg/day) may not achieve adequate blood levels and are associated with higher flare rates in lupus nephritis 2, 3
Failing to adjust for renal impairment is the greatest modifiable risk factor for toxicity and must not be overlooked 1
Inadequate monitoring in East Asian patients may miss early pericentral toxicity in this population 1
The goal is to safely maintain hydroxychloroquine as long as possible, not to discontinue it casually 1, 5